Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Encyclopedias
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol. 2009 Aug; 66(2):235-44.
View in:
PubMed
subject areas
Amyotrophic Lateral Sclerosis
Antioxidants
Clinical Trials, Phase III as Topic
Double-Blind Method
Female
Follow-Up Studies
Humans
Male
Medication Adherence
Middle Aged
Severity of Illness Index
Time Factors
Treatment Outcome
Ubiquinone
authors with profiles
Kourosh Rezania